BOTOX® Treatment in Pediatric Lower Limb Spasticity: Open-label Study

Trial Profile

BOTOX® Treatment in Pediatric Lower Limb Spasticity: Open-label Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Muscle spasticity
  • Focus Adverse reactions; Registrational
  • Sponsors Allergan
  • Most Recent Events

    • 10 Jun 2015 Planned End Date changed from 1 Jul 2017 to 1 Aug 2018 as reported by ClinicalTrials.gov record.
    • 10 Jun 2015 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2018 as reported by ClinicalTrials.gov record.
    • 22 Dec 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2012-000084-24)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top